Treatment with FLT3 inhibitor in patients with FLT3 -mutated acute myeloid leukemia is associated with development of secondary FLT3 -tyrosine kinase domain mutations

✍ Scribed by Alvarado, Yesid; Kantarjian, Hagop M.; Luthra, Rajyalakshmi; Ravandi, Farhad; Borthakur, Gautam; Garcia-Manero, Guillermo; Konopleva, Marina; Estrov, Zeev; Andreeff, Michael; Cortes, Jorge E.

• Book ID: 127186806
• Publisher: John Wiley and Sons
• Year: 2014
• Tongue: English
• Weight: 144 KB
• Volume: 120
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.28705